Journey Medical Corporation (DERM)

3,4500 +0,1200 (+3,60%) A partir del 12:25PM EDT. Mercado abierto.

Journey Medical Corporation

9237 East Via de Ventura Boulevard
Suite 105
Scottsdale, AZ 85258
United States
480 434 6670
https://journeymedicalcorp.com

Sector(es): Healthcare
Sector: Drug Manufacturers - Specialty & Generic
Empleados a tiempo completo: 41

Ejecutivos clave

Nombre	Título	Paga	Ejecutado	Año de nacimiento
Dr. Lindsay Allan Rosenwald	Executive Chairman	50k	N/A	1955
Mr. Claude Maraoui	Founder, President, CEO & Director	820,3k	N/A	1967
Mr. Joseph M. Benesch	Interim CFO & Corporate Controller	N/A	N/A	1967
Mr. Andrew J. Zwible	Vice President of Operations	N/A	N/A	N/A
Mr. Ramsey Alloush	General Counsel & Company Secretary	N/A	N/A	1986
Mr. Robert Nevin	Chief Commercial Officer	N/A	N/A	1968
Jaclyn Jaffe	Senior Director of Corporate Operations	N/A	N/A	N/A

Los importes son a partir de 31 de diciembre de 2022 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Paga es el salario, las bonificaciones, etc. Ejecutado es el valor de las opciones ejecutadas durante el año fiscal. Divisa en USD.

Descripción

Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant nodular acne; and Amzeeq, a topical formulation of minocycline for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris. It also offers Zilxi, a topical minocycline treatment for inflammatory lesions of rosacea; Exelderm cream and solution an antifungal intended for topical use; Targadox, an oral doxycycline drug for adjunctive therapy for severe acne; and Luxamend, a water-based emulsion formulated to provide a moist healing environment for superficial wounds; minor cuts or scrapes; dermal ulcers; donor sites; first- and second-degree burns, including sunburns; and radiation dermatitis. In addition, the company sells sulconazole nitrate cream and solution indicated for the treatment of tinea cruris, tinea corporis, and tinea versicolor; and doxycycline hyclate tablets, as an adjunctive therapy for severe acne. The company was formerly known as Coronado Dermatology, Inc. and changed its name to Journey Medical Corporation. Journey Medical Corporation was incorporated in 2014 and is headquartered in Scottsdale, Arizona. Journey Medical Corporation is a subsidiary of Fortress Biotech, Inc.

Gobierno corporativo

El ISS Governance QualityScore de Journey Medical Corporation, a día N/A, es N/A. Las puntuaciones base son Auditoría: N/A; Tablero: N/A; Derechos de los accionistas: N/A; Compensación: N/A.

Puntuación de gobierno corporativo cedida por Institutional Shareholder Services (ISS). Las puntuaciones indican un rango decil relativo al índice o región. Una puntuación decil de 1 indica un menor riesgo de gobierno, mientras que un 10 indica un riesgo de gobierno superior.